Ruffer LLP’s Amgen AMGN Stock Holding History

Ruffer LLP’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,561	Closed	-$2.79M	–	81
2019 Q4	$2.79M	Sell	11,561 -991,194	-99%	-$218M	0.08%	44
2019 Q3	$194M	Sell	1,002,755 -43,585	-4%	-$8.37M	5.51%	5
2019 Q2	$193M	Buy	+1,046,340	New	+$187M	4.5%	7

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ruffer LLP's AMGN Position: Q1 2020 in Review

Ruffer LLP sold out of Amgen (AMGN) in Q1 2020, closing a stake of 11,561 shares — an estimated $2.79M sold.

Ruffer LLP first reported a position in AMGN in Q2 2019 and held it in 3 quarters. The position peaked at $194M in Q3 2019. 2,028 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

Ruffer LLP reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
Ruffer LLP sold 11,561 Amgen shares in Q1 2020, an estimated $2.79M.
Ruffer LLP first reported a position in Amgen in Q2 2019 and held it in 3 quarters.
Ruffer LLP's Amgen position peaked at $194M in Q3 2019.
2,028 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Ruffer LLP's 13F filing for Q1 2020, filed 7 May 2020.